Development of a rapid, sensitive detection method for SARS‐CoV‐2 and influenza virus based on recombinase polymerase amplification combined with CRISPR‐Cas12a assay

Abstract excerpt

Abstract Respiratory tract infections are associated with the most common diseases transmitted among people and remain a huge threat to global public health. Rapid and sensitive diagnosis of causative agents is critical for timely treatment and disease control. Here, we developed a novel method based on recombinase polymerase amplification (RPA) combined with CRISPR‐Cas12a to detect three viral pathogens,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Biosensors and Analytical Detection
• Share to CRISPR and Genetic Engineering
• Share to SARS-CoV-2 detection and testing